Aarti Drugs Posts Steady Q4 Performance With ₹7.2 Billion Revenue

Ashik Bothra May 15, 2026 170 Views

Aarti Drugs reported consolidated revenue of ₹7.2 billion and a net profit of ₹552.6 million for the March quarter, reflecting stable operational performance. The results highlight resilience in the pharmaceutical business amid cost pressures, with steady demand supporting topline growth and profitability in a competitive environment.